Canopy Growth Corp Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Canopy Growth Corp (CGC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of 1.41 CAD/shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-06-30 was 1.41 CAD/shares, a 29.50% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-06-30 was 2.00 CAD/shares, a 80.73% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-06-30 was 10.38 CAD/shares, a 1574.19% increase year-over-year.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-06-30 was 0.62 CAD/shares, a 87.19% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was 2.00 CAD/shares, a 77.30% decline from fiscal 2025.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was 8.81 CAD/shares, a 41.64% increase from fiscal 2024.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was 6.22 CAD/shares, a 87.38% decline from fiscal 2023.
- Canopy Growth Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was 49.30 CAD/shares.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.41 CAD/shares 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 2.00 CAD/shares 10-K · filed 2026-06-15 | |||
| 2025-12-31 | 2.00 CAD/shares 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | 2.00 CAD/shares 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 2.00 CAD/shares 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | 8.81 CAD/shares 10-K · filed 2026-06-15 | |||
| 2024-12-31 | 10.37 CAD/shares 10-Q · filed 2025-02-07 | |||
| 2024-09-30 | 10.37 CAD/shares 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | 10.38 CAD/shares 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 6.22 CAD/shares 10-K · filed 2026-06-15 | |||
| 2023-12-31 | 6.22 CAD/shares 10-Q · filed 2024-02-09 | |||
| 2023-09-30 | 0.62 CAD/shares 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 0.62 CAD/shares 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 49.30 CAD/shares 10-K · filed 2025-05-30 | |||
| 2022-12-31 | 4.94 CAD/shares 10-Q · filed 2023-02-09 | |||
| 2022-09-30 | 4.75 CAD/shares 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 4.84 CAD/shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |